Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes

Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes

REGEN-COV is a SARS-CoV-2 combined monoclonal antibody treatment which has been shown to be effective in randomised controlled trials. Here, the authors assess its real-world effectiveness using data from Israel during the Delta wave and find that it reduced the risk of hospitalisation, severe disea...

Full description

Bibliographic Details
Main Authors: Samah Hayek, Yatir Ben-shlomo, Noa Dagan, Ben Y. Reis, Noam Barda, Eldad Kepten, Alina Roitman, Shachar Shapira, Shlomit Yaron, Ran D. Balicer, Doron Netzer, Alon Peretz
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-32253-9

Internet

https://doi.org/10.1038/s41467-022-32253-9

Similar Items